Table 5.

MRI diagnostic performance on axillary lymph node in current study combined with literature review

Author	Journal/Year	Patient numbers	Reference standard	Sensitivity (%)	Specificity (%)	NPV (%)	PPV (%)	Accuracy (%)
Yoshimura et al. [13]	Breast Cancer/1999	202	ALND	79	93	87	89	88
Kvistad et al. [14]	Eur Radiol/2000	65	ALND	83	90	90	83	88
Orguc et al. [15]	Balkan Med J/2012	155	ALND	89	14	80*	21.4*	Not reported
He et al. [16]	Eur J Radiol/2012	136	ALND	33.3–86.5	95.2–98.2	1.9–16.7	66.7–82.6	18.5–96.2
Scaranelo et al. [17]	Radiology/2012	61	ALND/SLNB	88.4	82.4	94.7	69.4	85
Hwang et al. [18]	J Breast Cancer/2013	349	ALND/SLNB	47.8	88.7	82.6	60.2	77.9
Hieken et al. [19]	Surgery/2013	505	ALND/SLNB	54.2	78.2	75.7	57.7	69.7
Abe et al. [20]	Acad Radiol/2013	50	ALND/SLNB	60	79	81	59	74
An et al. [21]	Nuklearmedizin/2014	132	ALND	67.5	78	79.2	65.9	74
Arslan et al. [22]	Springerplus/2016	35	SLNB	73.3	95	82.6	91.7	85.7
Hyun et al. [23]	Eur J Radiol/2016	425	ALND/SLNB	51.3	92.2	83.3	71.4	80.9
Barco et al. [24]	Clin Transl Oncol/2016	1351	ALND/SLNB	29.8	96.6	68.4	84.9	Not reported
Atallah et al. [25]	Breast J/2020	169	ALND/SLNB	70.3	87.5	76.2	83.3	Not reported
Zhao et al. [26]	Eur J Radiol/2020	265	ALND/SLNB	72.7	87.1	71	94.3	Not reported
Chen et al.	Current study	2473#	ALND/SLNB	63.2 (544/861)	68.5 (1104/1612)	77.7 (1104/1421)	51.7 (544/1052)	66.6 (1648/2473)

MRI magnetic resonance imaging, PPV positive predictive value, NPV negative predictive value, ALND axillary lymph node dissection, SLNB sentinel lymph node biopsy

*Calculated parameters

^#All these 2473 cases were primary operable invasive breast cancer patients